UK co-ordinating investigator international clinical trial: A Phase 2 Study to Assess the Efficacy and Safety of CAL-101 in Patients with Indolent B-Cell Non-Hodgkin Lymphoma Refractory to Rituximab and Alkylating Agents

Activity: Other

Description

Sep 2010Oct 2013

External organisation (UK Industry, Commerce & Public Corporations)

NameGilead Sciences Europe Ltd
Location2 Roundwood Avenue
CityUxbridge
CountryUnited Kingdom